Abbott Laboratories
NYSE: ABT
$114.15
-$0.73 (-0.6%)
Closing Price on September 19, 2024
ABT Articles
ThinkstockHealth care has been a top sector for investors this year. The research team at Oppenheimer continues to believe that health care remains well positioned to deliver further market-topping...
Published:
ThinkstockWhen the markets go through periods of great gains, it is not uncommon to see companies start to take more radical efforts to increase their total return for shareholders. Some may go...
Published:
Courtesy of Abbott LaboratoriesWith many of the companies in the S&P 500 having margins approaching all-time highs, and implied S&P 500 correlations approaching post-crisis lows, it is...
Published:
Frank Golhen, via Wikimedia CommonsWith the equity markets seemingly hitting new all-time highs every day, we were intrigued by the makeup of the new UBS A.G. (NYSE: UBS) Equity Focus List. The...
Published:
Last Updated:
ThinkstockThe U.K.’s royal family is wealthy, but likely not wealthy enough to pass up sponsorships as the heir to the thrown is born to Kate, the wife to Prince William. Or, perhaps the family...
Published:
ThinkstockFollowing last month’s Federal Open Market Committee (FOMC) meeting, the euro-U.S. dollar exchange rate (EURUSD) fell to just over 80. Less than a month later the EURUSD came within a...
Published:
Last Updated:
July 17, 2013: U.S. equity markets opened higher this morning and managed to hold onto a decent gain following a day of ups and downs as Fed Chairman Ben Bernanke testified before Congress. While...
Published:
Last Updated:
ThinkstockAbbott Laboratories (NYSE: ABT) reported second-quarter 2013 results before markets opened this morning. The drugmaker reported adjusted diluted earnings per share (EPS) of $0.46 on...
Published:
Last Updated:
July 16, 2013: U.S. equity markets opened a bit higher this morning but almost instantly turned lower and remained in the red virtually all day. In Europe, Germany’s ZEW economic sentiment survey...
Published:
Last Updated:
ThinkstockAs the pharmaceuticals industry looks toward restructuring and separation of undervalued assets, Jefferies analysts have prepared a highly proprietary sum of the parts analysis for their...
Published:
Last Updated:
U.S. equity markets opened lower this morning but soon rose above the break-even line where it stayed until noon when share prices began to dip. That was quite a shift from Asian markets, where the...
Published:
Last Updated:
These are the top analyst upgrades and stocks to buy from select Wall Street research calls on May 20, 2013. They include J.C. Penney, Pandora Media, Priceline.com and T-Mobile US.
Published:
Last Updated:
Wikimedia CommonsYesterday’s announcement by Pfizer Inc. (NYSE: PFE) that it would begin selling its blockbuster Viagra drug online directly to patients is a genuinely ground-breaking deal. The big...
Published:
Last Updated:
ThinkstockThe world of pharmaceuticals may have faced a patent cliff in recent years, but brand name drugs are still generating billions upon billions in annual sales in the United States alone. Some...
Published:
Last Updated:
ThinkstockAbbVie Inc. (NYSE: ABBV) reported first-quarter 2013 results before markets opened this morning. The pharmaceutical research firm posted adjusted diluted earnings per share (EPS) of $0.68...
Published:
Last Updated: